Silo Pharma, Inc. (SILO) Form 8-K — Nov 6, 2026
Silo Pharma entered into securities purchase agreements on November 5, 2026 for a private placement of 136,005 shares at $1.50 per share plus pre-funded warrants for 430,661 shares at $1.4999, for gross proceeds of approximately $1.1 million. The offering closed on November 6, 2026, with expected net proceeds of roughly $815,000 after fees, earmarked for working capital and general corporate purposes. The pre-funded warrants are immediately exercisable at a nominal $0.0001 exercise price.
Key figures
- Gross Proceeds
- 1100000
- Offering Price
- 1.5
- Shares Offered
- 136005
- Net Proceeds
- approximately $815,000
- Registration Deadline
- file within 30 days; effective within 60 days (90 if full SEC review)
- Warrant Exercise Price
- 0.0001
- Pre Funded Warrant Price
- 1.4999
- Pre Funded Warrant Shares
- 430661
- Beneficial Ownership Limit
- 4.99% (electable to 9.99%)
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.